Drug Shortage Report for PMS-METHOTREXATE INJECTION
| Report ID | 250578 |
| Drug Identification Number | 02539616 |
| Brand name | PMS-METHOTREXATE INJECTION |
| Common or Proper name | METHOTREXATE |
| Company Name | PHARMASCIENCE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | METHOTREXATE |
| Strength(s) | 12.5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 0.25mL |
| ATC code | L04AX |
| ATC description | IMMUNOSUPPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-02-17 |
| Estimated end date | 2025-03-17 |
| Actual end date | 2025-03-16 |
| Shortage status | Resolved |
| Updated date | 2025-03-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2025-03-17 | French | Compare |
| v4 | 2025-03-17 | English | Compare |
| v3 | 2025-02-18 | French | Compare |
| v2 | 2025-02-18 | English | Compare |
| v1 | 2025-02-18 | English | Compare |
Showing 1 to 5 of 5